The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes

Science

Volumn 330, Issue 6009, 2010, Pages 1340-1344

  Levine, Arnold J ^a,b   Puzio Kuter, Anna M ^b  

^a INSTITUTE FOR ADVANCED STUDY   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARBON DIOXIDE; GLUCOSE; LACTIC ACID; TUMOR SUPPRESSOR PROTEIN; WATER;

CANCER; CARBON DIOXIDE; DISEASE TREATMENT; GENE EXPRESSION; GLUCOSE; METABOLISM; SECRETION; SUBSTRATE; TUMOR;

ADULT; AEROBIC METABOLISM; CANCER CELL; CELL DIVISION; CELL GROWTH; CONTROLLED STUDY; GLYCOLYSIS; HUMAN; NONHUMAN; ONCOGENE; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; TUMOR SUPPRESSOR GENE;

ADENOSINE TRIPHOSPHATE; CELL DIVISION; CITRIC ACID CYCLE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GLUCOSE; GLUTAMINE; GLYCOLYSIS; HUMANS; NADP; NEOPLASMS; ONCOGENES; PENTOSE PHOSPHATE PATHWAY; SIGNAL TRANSDUCTION;

EID: 78649711427     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1193494     Document Type: Review

References (39)

1. O. Warburg, K. Posener, E. Negelein, Biochem. Z. 152, 309 (1924).
2. O. Warburg, Science 123, 309 (1956).
3. P. P. Hsu, D. M. Sabatini, Cell 134, 703 (2008).
4. G. Kroemer, J. Pouyssegur, Cancer Cell 13, 472 (2008).
5. M. G. Vander Heiden, L. C. Cantley, C. B. Thompson, Science 324, 1029 (2009).
6. R. J. Deberardinis, N. Sayed, D. Ditsworth, C. B. Thompson, Curr. Opin. Genet. Dev. 18, 54 (2008).
7. J. W. Locasale, L. C. Cantley, M. G. Vander Heiden, Nat. Biotechnol. 27, 916 (2009).
8. D. A. Tennant, R. V. Durán, H. Boulahbel, E. Gottlieb, Carcinogenesis 30, 1269 (2009).
9. E. Gottlieb, K. H. Vousden, in The p53 Family, A. J. Levine, D. Lane, Eds. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2010), pp. 187-198.
10. T. K. Hunt et al., Antioxid. Redox Signal. 9, 1115 (2007).
11. H. R. Christofk, M. G. Vander Heiden, N. Wu, J. M. Asara, L. C. Cantley, Nature 452, 181 (2008).
12. G. L. Semenza, Nat. Rev. Cancer 3, 721 (2003).
13. M. L. Macheda, S. Rogers, J. D. Best, J. Cell. Physiol. 202, 654 (2005).
14. R. K. Bruick, S. L. McKnight, Science 294, 1337 (2001); 10.1126/science.1066373.
15. K. S. Hewitson, L. A. McNeill, J. M. Elkins, C. J. Schofield, Biochem. Soc. Trans. 31, 510 (2003).
16. P. H. Maxwell et al., Nature 399, 271 (1999).
17. R. J. DeBerardinis et al., Proc. Natl. Acad. Sci. U.S.A. 104, 19345 (2007).
18. C. V. Dang, Mol. Cell. Biol. 19, 1 (1999).
19. K. Bensaad et al., Cell 126, 107 (2006).
20. S. Matoba et al., Science 312, 1650 (2006); 10.1126/science.1126863.
21. A. V. Budanov, A. A. Sablina, E. Feinstein, E. V. Koonin, P. M. Chumakov, Science 304, 596 (2004).
22. W. Hu et al., Proc. Natl. Acad. Sci. U.S.A. 107, 7455 (2010).
23. S. Suzuki et al., Proc. Natl. Acad. Sci. U.S.A. 107, 7461 (2010).
24. Z. Feng et al., Cancer Res. 67, 3043 (2007).
25. Z. Feng, in The p53 Family, A. J. Levine, D. Lane, Eds. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2010), pp. 199-298.
26. A. V. Budanov, M. Karin, Cell 134, 451 (2008).
27. Z. Feng, H. Zhang, A. J. Levine, S. Jin, Proc. Natl. Acad. Sci. U.S.A. 102, 8204 (2005).
28. D. W. Parsons et al., Science 321, 1807 (2008); 10.1126/science.1164382.
29. H. Yan et al., N. Engl. J. Med. 19, 765 (2009).
30. P. S. Ward et al., Cancer Cell 16, 225 (2010).
31. M. Kranendijk et al., Science 330, 336 (2010); 10.1126/science.1192632.
32. L. Dang et al., Nature 17, 966 (2010).
33. J. M. Evans, L. A. Donnelly, A. M. Emslie-Smith, D. R. Alessi, A. D. Morris, BMJ 330, 1304 (2005).
34. S. Jiralerspong et al., J. Clin. Oncol. 27, 3297 (2009).
35. M. Buzzai et al., Cancer Res. 67, 6745 (2007).
36. A. Bourdon et al., Nat. Genet. 39, 776 (2007).
37. T. Minamino et al., Nat. Med. 15, 1082 (2009).
38. R. H. Kim et al., Cancer Cell 7, 263 (2005).
39. P. Ak, A. J. Levine, FASEB J. 24, 3643 (2010).